Literature DB >> 24449209

B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins.

Patrick P Ng1, Chiung-Chi Kuo, Stanley Wang, Shirit Einav, Luca Arcaini, Marco Paulli, Carol S Portlock, Joseph Marcotrigiano, Alexander Tarr, Jonathan Ball, Ronald Levy, Shoshana Levy.   

Abstract

Chronic hepatitis C virus (HCV) infection has been implicated in the induction and maintenance of B-cell lymphomas. The strongest evidence for this derives from clinical observations of tumor regressions upon antiviral treatments. Here we used multiple methods to test the hypothesis that the expansion of HCV-specific B cells gives rise to lymphomas. We obtained lymphoma tissues from HCV-infected lymphoma patients, including some that later regressed upon antiviral treatments. We expressed the lymphoma B-cell receptors as soluble immunoglobulin Gs and membrane IgMs, and analyzed their reactivity with HCV proteins and with HCV virions. We confirmed previous reports that HCV-associated lymphomas use a restricted immunoglobulin variable region gene repertoire. However, we found no evidence for their binding to the HCV antigens. We conclude that most lymphomas of HCV-infected patients do not arise from B cells aimed at eliminating the virus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24449209      PMCID: PMC3945861          DOI: 10.1182/blood-2013-10-532895

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals.

Authors:  Miroslaw K Gorny; Ruimin Pan; Constance Williams; Xiao-Hong Wang; Barbara Volsky; Timothy O'Neal; Brett Spurrier; Jared M Sampson; Liuzhe Li; Michael S Seaman; Xiang-Peng Kong; Susan Zolla-Pazner
Journal:  Virology       Date:  2012-03-07       Impact factor: 3.616

2.  B cell development regulated by gene rearrangement: arrest of maturation by membrane-bound D mu protein and selection of DH element reading frames.

Authors:  H Gu; D Kitamura; K Rajewsky
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

3.  V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen.

Authors:  C H Chan; K G Hadlock; S K Foung; S Levy
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

4.  Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5.

Authors:  Nobuko Ohshima; Yoshitaka Iba; Ritsuko Kubota-Koketsu; Yoshizo Asano; Yoshinobu Okuno; Yoshikazu Kurosawa
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

5.  Blocking hepatitis C virus infection with recombinant form of envelope protein 2 ectodomain.

Authors:  Jillian Whidby; Guaniri Mateu; Hannah Scarborough; Borries Demeler; Arash Grakoui; Joseph Marcotrigiano
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

6.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

7.  Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

Authors:  M E Reff; K Carner; K S Chambers; P C Chinn; J E Leonard; R Raab; R A Newman; N Hanna; D R Anderson
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

Review 8.  Hepatitis C virus proteins: from structure to function.

Authors:  Darius Moradpour; François Penin
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly.

Authors:  Gregory Neveu; Rina Barouch-Bentov; Amotz Ziv-Av; Doron Gerber; Yves Jacob; Shirit Einav
Journal:  PLoS Pathog       Date:  2012-08-16       Impact factor: 6.823

Review 10.  Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).

Authors:  Giuseppe Sautto; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-08       Impact factor: 5.048

View more
  8 in total

1.  Identification of a novel stereotypic IGHV4-59/IGHJ5-encoded B-cell receptor subset expressed by various B-cell lymphomas with high affinity rheumatoid factor activity.

Authors:  Richard J Bende; Jerry Janssen; Thera A M Wormhoudt; Koen Wagner; Jeroen E J Guikema; Carel J M van Noesel
Journal:  Haematologica       Date:  2016-02-08       Impact factor: 9.941

Review 2.  Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?

Authors:  Barbara Vannata; Luca Arcaini; Emanuele Zucca
Journal:  Ther Adv Hematol       Date:  2015-12-29

3.  Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system.

Authors:  Richard Y Wang; Patricia Bare; Valeria De Giorgi; Kentaro Matsuura; Kazi Abdus Salam; Teresa Grandinetti; Cathy Schechterly; Harvey J Alter
Journal:  Hepatology       Date:  2016-10-24       Impact factor: 17.425

Review 4.  Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.

Authors:  Romeo-Gabriel Mihăilă
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

5.  Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders.

Authors:  B Dai; A Y Chen; C P Corkum; R J Peroutka; A Landon; S Houng; P A Muniandy; Y Zhang; E Lehrmann; K Mazan-Mamczarz; J Steinhardt; M Shlyak; Q C Chen; K G Becker; F Livak; T I Michalak; R Talwani; R B Gartenhaus
Journal:  Oncogene       Date:  2015-10-05       Impact factor: 9.867

Review 6.  Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.

Authors:  Michele Merli; Giuseppe Carli; Luca Arcaini; Carlo Visco
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

Review 7.  New insights into HCV-related rheumatologic disorders: A review.

Authors:  Patrice Cacoub; Cloé Comarmond
Journal:  J Adv Res       Date:  2016-07-25       Impact factor: 10.479

8.  The Pivotal Role of Viruses in the Pathogeny of Chronic Lymphocytic Leukemia: Monoclonal (Type 1) IgG K Cryoglobulinemia and Chronic Lymphocytic Leukemia Diagnosis in the Course of a Human Metapneumovirus Infection.

Authors:  Jérémy Barben; Alain Putot; Anca-Maria Mihai; Jérémie Vovelle; Patrick Manckoundia
Journal:  Viruses       Date:  2021-01-16       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.